At ApiSyn, we deliver high-quality, GMP-certified active pharmaceutical ingredients (APIs) that meet global regulatory standards
At ApiSyn, we deliver high-quality, GMP-certified active pharmaceutical ingredients (APIs) that meet global regulatory standards. With a commitment to innovation, quality and regulatory excellence, we deliver cost-effective and reliable API solutions to leading pharmaceutical companies worldwide.
| # | Product Name | CAS No. | Regulatory Status | Therapeutic Category | Status | Enquiry |
|---|---|---|---|---|---|---|
| 1 | 850649-62-6 | Anti-Diabetics | Commercialized | EnquiryDetails | ||
| 2 | 503612-47-3 | Anti-Coagulants | Commercialized | EnquiryDetails | ||
| 3 | 677007-74-8 | TPO Receptor Agonists | Under Development | EnquiryDetails | ||
| 4 | 1428652-17-8 | Under Development | EnquiryDetails | |||
| 5 | 202189-78-4 | Anti-histamine | Under Development | EnquiryDetails | ||
| 6 | 2923839-30-7 | Under Development | EnquiryDetails | |||
| 7 | 461432-26-8 | Under Development | EnquiryDetails | |||
| 8 | 1971128-01-4 | Under Development | EnquiryDetails | |||
| 9 | 960404-48-2 | Anti-Diabetics | Under Development | EnquiryDetails | ||
| 10 | 1263774-59-9 | Under Development | EnquiryDetails | |||
| 11 | 923978-27-2 | Antihyperlipidemic | Under Development | EnquiryDetails | ||
| 12 | 864070-44-0 | Anti-Diabetics | Under Development | EnquiryDetails | ||
| 13 | 83928-66-9 | Anti-depressant | Under Development | EnquiryDetails | ||
| 14 | 1624306-20-2 | Under Development | EnquiryDetails | |||
| 15 | 873054-44-5 | Cystic Fibrosis | Under Development | EnquiryDetails | ||
| 16 | 165800-03-3 | Anti-biotic | Commercialized | EnquiryDetails | ||
| 17 | 165800-03-3 | Anti-biotic | Commercialized | EnquiryDetails | ||
| 18 | 21498-08-8 | Opioid withdrawal | Under Development | EnquiryDetails | ||
| 19 | 441798-33-0 | Anti-hypertensive | Under Development | EnquiryDetails | ||
| 20 | 1642288-47-8 | Myosin inhibitor | Under Development | EnquiryDetails | ||
| 21 | 41100-52-1 | Commercialized | EnquiryDetails | |||
| 22 | 60-56-0 | Anti-thyroid | Commercialized | EnquiryDetails | ||
| 23 | 223673-61-8 | Under Development | EnquiryDetails | |||
| 24 | 3069331-78-5 | Under Development | EnquiryDetails | |||
| 25 | 1415477-49-4 | Under Development | EnquiryDetails | |||
| 26 | 903576-44-3 | CNS Stimulants | Under Development | EnquiryDetails | ||
| 27 | 95635-56-6 | Under Development | EnquiryDetails | |||
| 28 | 1787294-07-8 | Under Development | EnquiryDetails | |||
| 29 | 920509-32-6 | Under Development | EnquiryDetails | |||
| 30 | 1575596-29-0 | Under Development | EnquiryDetails | |||
| 31 | 1374024-48-2 | Under Development | EnquiryDetails | |||
| 32 | 366789-02-8 | Anti-Coagulants | Commercialized | EnquiryDetails | ||
| 33 | 928821-40-3 | PPAR-delta agonist | Under Development | EnquiryDetails | ||
| 34 | 242478-38-2 | Anti-muscarinic | Under Development | EnquiryDetails | ||
| 35 | 959-24-0 | Anti-arrhythmic | Commercialized | EnquiryDetails | ||
| 36 | 26921-17-5 | Under Development | EnquiryDetails | |||
| 37 | 2050057-56-0 | Under Development | EnquiryDetails | |||
| 38 | 274901-16-5 | Anti-Diabetics | Under Development | EnquiryDetails | ||
| 39 | 881681-01-2 | Anti-biotic | Under Development | EnquiryDetails | ||
| 40 | 152854-19-8 | Under Development | EnquiryDetails |
As an emerging player in the API manufacturing industry, our company is dedicated to delivering high-quality Active Pharmaceutical Ingredients through innovative processes, stringent quality control, and a strong commitment to global regulatory standards. Our growing portfolio reflects our focus on therapeutic relevance, efficiency, and scalability. The attached list of products showcases our current range of APIs, developed to meet the needs of both domestic and international markets.
